ULTRAGENYX EUROPE GMBH
502078-5456ActiveAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Översikt
- 1–4
- Anställda
- Okänt
- Omsättning
- 2022
- Grundat
Nyckelbeslutsfattare
Emil D. Kakkis
Chief Executive Officer and President
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President
Beskrivning
Ultragenyx is a dedicated biopharmaceutical company focused on transforming the lives of individuals living with rare and ultra-rare genetic diseases. The organization commits itself daily to the development and delivery of novel treatments where none currently exist. They achieve this by exploring...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- Utländsk juridisk person
- Momsnummer
- SE502078545601
Beslutsfattare
2 kontakter i FunnelfeedrEmil D. Kakkis
Chief Executive Officer and President
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President
Liknande företag
20 liknande företag i FunnelfeedrBridgeBio International GmbH
1–4 anställdaDeveloping transformative medicines for rare genetic conditions quickly.
SAREPTA THERAPEUTICS, INC.
0 anställdaEngineering precision genetic medicine to rescue lives from rare diseases.
OxThera Intellectual Property AB
0 anställdaDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Orchard Therapeutics (Sweden) AB
1–4 anställdaDeveloping life-transforming HSC gene therapies for severe genetic diseases.
AMICUS THERAPEUTICS LTD
1–4 anställdaGlobal biotechnology company developing transformative medicines for rare diseases.
Utforska mer
Frågor om ULTRAGENYX EUROPE GMBH
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo